Pharmacological manipulation of the ductus arteriosus.
作者信息
Silove E D
出版信息
Arch Dis Child. 1986 Sep;61(9):827-9. doi: 10.1136/adc.61.9.827.
Abstract
摘要
相似文献
1
Pharmacological manipulation of the ductus arteriosus.动脉导管的药物调控
Arch Dis Child. 1986 Sep;61(9):827-9. doi: 10.1136/adc.61.9.827.
2
The ductus arteriosus: why and how to manipulate its patency.动脉导管：为何以及如何控制其通畅性。
J Fla Med Assoc. 1983 Sep;70(9):788-93.
3
Medical treatment of the ductus arteriosus.动脉导管的医学治疗。
Hosp Pract. 1977 Feb;12(2):57-65. doi: 10.1080/21548331.1977.11707078.
4
Prostaglandins and the management of congenital heart disease.前列腺素与先天性心脏病的治疗
Am Fam Physician. 1982 Dec;26(6):127-32.
5
Cardiovascular therapy in the newborn.新生儿心血管治疗
Clin Invest Med. 1985;8(4):360-7.
6
Comments on the pharmacologic manipulation of the ductus arteriosus in newborns.关于新生儿动脉导管药物调控的评论
Adv Prostaglandin Thromboxane Res. 1978;4:383-5.
7
Medical manipulation of the ductus arteriosus.动脉导管的医学干预。
Lancet. 1975 Jan 18;1(7899):140-2. doi: 10.1016/s0140-6736(75)91432-4.
8
9
Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn.前列腺素及前列腺素合成酶抑制剂在新生儿心脏问题中的临床应用。
Adv Prostaglandin Thromboxane Res. 1980;7:913-6.
10
Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.给予前列腺素E1治疗动脉导管依赖性先天性心脏病后动脉导管的形态学特征。
J Am Coll Cardiol. 1983 Feb;1(2 Pt 1):471-5. doi: 10.1016/s0735-1097(83)80075-8.
引用本文的文献
1
The future potential of eicosanoids and their inhibitors in paediatric practice.类花生酸及其抑制剂在儿科临床实践中的未来潜力。
Drugs. 1998 Aug;56(2):169-76. doi: 10.2165/00003495-199856020-00001.
2
Congenital heart disease: the ductus arteriosus as pathfinder.先天性心脏病：动脉导管作为先导。
Br Heart J. 1987 Nov;58(5):429-36. doi: 10.1136/hrt.58.5.429.
3
Effect of infusion rate of indomethacin on cerebrovascular responses in preterm neonates.吲哚美辛输注速率对早产儿脑血管反应的影响。
Arch Dis Child. 1989 Jan;64(1 Spec No):8-12. doi: 10.1136/adc.64.1_spec_no.8.
本文引用的文献
1
Oral prostaglandin E2 in ductus-dependent pulmonary circulation.口服前列腺素E2在依赖动脉导管的肺循环中的作用
Circulation. 1981 Mar;63(3):682-8. doi: 10.1161/01.cir.63.3.682.
2
Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.患有动脉导管依赖性先天性心脏病的前列腺素E1婴儿。
Circulation. 1981 Nov;64(5):899-905. doi: 10.1161/01.cir.64.5.899.
3
Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease.前列腺素E1治疗重症先天性心脏病婴儿的副作用。
Circulation. 1981 Nov;64(5):893-8. doi: 10.1161/01.cir.64.5.893.
4
Clinical course to 1 year of age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin.动脉导管未闭早产儿至1岁时的临床病程：吲哚美辛多中心随机试验的结果
J Pediatr. 1984 Aug;105(2):285-91. doi: 10.1016/s0022-3476(84)80134-1.
5
Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.
J Pediatr. 1983 Jun;102(6):895-906. doi: 10.1016/s0022-3476(83)80022-5.
6
Evaluation of oral and low dose intravenous prostaglandin E2 in management of ductus dependent congenital heart disease.口服及低剂量静脉注射前列腺素E2治疗动脉导管依赖性先天性心脏病的疗效评估
Arch Dis Child. 1985 Nov;60(11):1025-30. doi: 10.1136/adc.60.11.1025.
7
Early administration of indomethacin to preterm infants.对早产儿尽早给予吲哚美辛。
Arch Dis Child. 1986 Mar;61(3):233-8. doi: 10.1136/adc.61.3.233.
8
Lamb ductus arteriosus: effect of prostaglandin synthesis inhibitors on the muscle tone and the response to prostaglandin E2.羔羊动脉导管：前列腺素合成抑制剂对肌张力及对前列腺素E2反应的影响
Prostaglandins. 1975 Feb;9(2):299-308. doi: 10.1016/0090-6980(75)90034-9.
9
Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities.前列腺素E1对主动脉弓畸形中动脉导管的扩张作用。
Circulation. 1979 Jan;59(1):169-73. doi: 10.1161/01.cir.59.1.169.
10
Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins.
Circulation. 1977 Feb;55(2):238-41. doi: 10.1161/01.cir.55.2.238.
Zotero 插件